Tsuruoka A, Kaku Y, Kakinuma H, Tsukada I, Yanagisawa M, Naito T
Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan.
Chem Pharm Bull (Tokyo). 1997 Jul;45(7):1169-76. doi: 10.1248/cpb.45.1169.
A new series of thiazole-containing triazole antifungals was synthesized and evaluated for antifungal activity against a variety of clinically isolated pathogenic fungi in vitro and against systemic candidosis in vivo. Among these compounds, (+/-)-1-(2,4-difluorophenyl)-1-[4-(2,4-difluorophenyl) thiazol-2-yl]-2-(1H-1,2,4-triazol-1-yl)ethanol (ER24161) showed the most potent and well-balanced in vitro activities and excellent in vivo efficacy. We also achieved an enantioselective synthesis of the more potent enantiomer of ER-24161.
合成了一系列含噻唑的三唑类抗真菌剂,并对其体外抗多种临床分离致病真菌的活性以及体内抗系统性念珠菌病的活性进行了评估。在这些化合物中,(±)-1-(2,4-二氟苯基)-1-[4-(2,4-二氟苯基)噻唑-2-基]-2-(1H-1,2,4-三唑-1-基)乙醇(ER24161)表现出最有效的体外活性和良好的平衡,并且体内疗效优异。我们还实现了对ER-24161更有效对映体的对映选择性合成。